Home
About
Overview
Sharing Data
ORCID
Help
History (65)
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
A synthetic biology approach to the development of transcriptional regulatory models and custom enhancer design.
BMP signaling in mesenchymal stem cell differentiation and bone formation.
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study.
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.
See All 65 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years. J Urol. 2005 Dec; 174(6):2154-7, discussion 2157.
View in:
PubMed
subject areas
Age Factors
Aged
Biomarkers, Tumor
Biopsy
Humans
Male
Middle Aged
Predictive Value of Tests
Prostate-Specific Antigen
Prostatic Neoplasms
Tumor Burden
authors with profiles
Scott Eggener